- Companies
- Centre for Sight
Centre for Sight Revenue, Valuation, Funding & Investors
Centre for Sight is valued at $192M as of May 2024, a 3.1x revenue multiple. Centre for Sight revenue was $62M and Centre for Sight EBITDA was $13M, as disclosed with its latest round.
Last Centre for Sight valuation
$192M
Undisclosed stage · May 2024
Last Centre for Sight funding round
$100M
Undisclosed stage · May 2024
Centre for Sight revenue
$62M
Undisclosed stage · May 2024
Key investors in Centre for Sight
Z47
ChrysCapital
Mahindra Partners
Mahipal Sachdev
Founded
1996
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Revenue
$62M (May 2024)
Valuation
$192M (May 2024)
Sectors
Centre for Sight Valuation
Centre for Sight is currently valued at $192M, based on its undisclosed-stage round in May 2024. Read the announcement ↗
The $100M round included ChrysCapital.
Centre for Sight valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| May 2024 | Undisclosed stage | $192M | 3.1x |
Centre for Sight Revenue
Centre for Sight's latest recorded revenue is $62M, as of its undisclosed-stage round in May 2024. At a $192M valuation, that implies a 3.1x revenue multiple.
Centre for Sight revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| May 2024 | $62M | $192M | 3.1x | Undisclosed stage |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Centre for Sight Funding History
Centre for Sight has raised a total of $137M across 3 funding rounds.
Centre for Sight's first fundraising round was a $5M Series A in July 2013. The most recent completed round was a $100M undisclosed-stage round in May 2024.
Centre for Sight funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| May 2024 | Undisclosed stage | ChrysCapital | $100M | $192M | ChrysCapital announced in May 2024 that it would invest up to USD 100 million in Centre for Sight, the New Delhi eye care chain, for a significant minority stake. The investment combines fresh primary capital for the company with the purchase of the entire holding of Mahindra Holdings, a subsidiary of Mahindra and Mahindra that had invested in the chain in 2019. The funds are to support expansion, including new greenfield centres and tuck-in acquisitions. ChrysCapital managing director Raghav Ramdev said healthcare is a key focus area for the firm given the underserved market, and described the chain as having shown robust growth. Founder Mahipal Sachdev welcomed ChrysCapital as a partner. Centre for Sight was founded in 1996 and is among the three largest organised eye care chains in India. As of March 2024 it ran 83 centres across 15 states and union territories and 39 cities, with annual patient footfall above 1.5 million. |
| May 2019 | Undisclosed stage | Mahindra Partners (lead); Mahipal Sachdev | $32M | - | Centre for Sight is an India-based ophthalmology chain founded in 1996 by Dr. Mahipal Sachdev, operating eye care centers across multiple cities that diagnose and treat eye disorders. On May 15, 2019, Mahindra Partners invested INR 206.5 crore in a mix of primary and secondary transactions, with promoters adding INR 20 crore, totaling INR 226.5 crore; this enabled early investor Matrix Partners India to fully exit its stake from a prior 2013 investment. The funds were intended to support organic growth by opening new centers, inorganic expansion through acquisitions, and consolidating leadership in the Indian ophthalmology healthcare segment. Mahindra Partners, the private equity arm of the Mahindra Group, highlighted Centre for Sight's leadership position and growth potential in the large, expanding eye care market, aligning with their healthcare investment focus including single specialty practices. Parag Shah, Managing Partner at Mahindra Partners, emphasized confidence in Dr. Mahipal Sachdev's team and their execution focus. The investment reflected Mahindra's values of sustainable growth and societal impact. In 2024, ChrysCapital invested up to $100 million in a mix of primary and secondary transactions, acquiring Mahindra Holdings' entire stake from the 2019 deal and taking a significant minority position to fuel further expansion into Tier I and II cities, building on the network of 83 centers across 39 cities at that time. This exit underscored the company's robust growth and profitability over the prior five years, including resilience during COVID. |
| Jul 2013 | Series A | Z47 | $5M | - | Centre for Sight, an Indian eye care chain founded in 1996 and incorporated in 2002 by Dr. Mahipal Sachdev, received a Series B investment from Z47 (formerly Matrix Partners India) on July 3, 2013. The company provides comprehensive eye-care services across multiple centers in India. Z47 later fully exited its stake in 2019 during Mahindra Partners' investment of INR 206.5 Cr in a mix of primary and secondary. |
Who has invested in Centre for Sight?
4 investors have backed Centre for Sight across its funding rounds, including Z47, ChrysCapital, Mahindra Partners and Mahipal Sachdev.
Lead investors include Mahindra Partners.
Centre for Sight Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | May 2019 | ||
| 1 | Participant | Jul 2013 | ||
This data is available for Pro users. Sign up to see all 4 Centre for Sight investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Centre for Sight
Centre for Sight has acquired 1 company to date.
Last acquisition by Centre for Sight was on September 4th 2024. Centre for Sight acquired Laxmi Eye Hospital and Institute for undisclosed valuation.
Latest Acquisitions by Centre for Sight
| Description | Laxmi Eye Hospital and Institute is a Kathmandu-based ophthalmology center offering cataract surgeries, glaucoma treatments, squint corrections, and retina services. Established in 2010, it performs 10,000-plus procedures annually, equipped with phacoemulsification units and OCT scanners, serving patients from Nepal and neighboring regions. |
| HQ Country | |
| HQ City | Mumbai |
| Deal Date | 4 Sep 2024 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Centre for Sight acquisitions and their M&A valuation multiples. Start Free Trial | |
Centre for Sight Competitors
Centre for Sight competitors include listed companies like Suraksha Diagnostics, Monash IVF Group and Oncoclínicas, and private ones like Apollo Health And Lifeestyle, Beep Saúde and Regency Healthcare.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $48M | - | $199M | 4.1x | ||
| Publicly listed | $33M | $10M | $185M | 5.4x | ||
| Publicly listed | $187M | $30M | $200M | 1.7x | ||
| Publicly listed | $1B | ($409M) | $201M | 0.8x | ||
| Private | $55M | - | $204M | 3.7x | ||
| Private | - | - | $180M | - |
Centre for Sight Public Comps
Centre for Sight is still privately-owned, but its public comps include Suraksha Diagnostics, Monash IVF Group, Oncoclínicas, Tınaztepe Sağlık, Pihlajalinna, Limes Schlosskliniken, Goodwill Pharma, Atrys Health, Centrum Medyczne ENEL-MED and Shalby.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $33M | $10M | 5.9x | 5.4x | 19.2x | 17.0x | |||
| $187M | $30M | 1.8x | 1.7x | 11.1x | 8.6x | |||
| $1B | ($409M) | 0.9x | 0.8x | (2.2x) | 6.9x | |||
| $68M | $21M | 2.4x | - | 7.7x | - | |||
| $732M | $122M | 0.5x | 0.6x | 3.3x | 4.0x | |||
| $56M | $14M | 3.1x | 2.5x | 12.0x | 10.2x | |||
| $70M | $18M | 2.7x | - | 10.1x | - | |||
| $158M | ($12M) | 2.2x | 2.0x | (29.1x) | 12.7x | |||
This data is available for Pro users. Sign up to see all Centre for Sight competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Centre for Sight
| When was Centre for Sight founded? | Centre for Sight was founded in 1996. |
| Where is Centre for Sight headquartered? | Centre for Sight is headquartered in India. |
| Is Centre for Sight publicly listed? | No, Centre for Sight is a private, VC-backed company. |
| What is Centre for Sight's valuation? | Centre for Sight was last valued at $192M in its undisclosed-stage round in May 2024. |
| How much funding has Centre for Sight raised? | Centre for Sight has raised $137M across 3 funding rounds. |
| What was Centre for Sight's last funding round? | Centre for Sight's last funding round was a $100M undisclosed-stage round in May 2024. |
| Who are Centre for Sight's investors? | Centre for Sight's investors include Mahipal Sachdev, Z47, Mahindra Partners and ChrysCapital. |
| What is Centre for Sight's revenue? | Centre for Sight's latest recorded revenue is $62M (May 2024). |
| What is Centre for Sight's revenue multiple? | Centre for Sight's latest valuation implies a 3.1x revenue multiple ($192M valuation on $62M of revenue). |
| Which companies are comparable to Centre for Sight? | Companies comparable to Centre for Sight include Apollo Health And Lifeestyle, Suraksha Diagnostics, Monash IVF Group, Oncoclínicas, Beep Saúde and Regency Healthcare. |
| How many companies has Centre for Sight acquired? | Centre for Sight has acquired 1 company, including Laxmi Eye Hospital and Institute. |
See companies similar to Centre for Sight
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




